What We're Reading: Page 103
Industry reads hand-picked by our editors
May 03, 2023
-
Fierce Pharma
Neurocrine gives up on Parkinson’s drug Ongentys
-
Reuters
Haleon not surprised by Pfizer stake sale plans, says CFO
-
Evaluate Vantage
Mirasol knockout puts the pressure on Sutro
May 02, 2023
-
Bloomberg
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It
-
The Wall Street Journal
In the Fight Against Aging, a Drug Called Rapamycin Captures Attention
-
Evaluate Vantage
The sellside hacks back Lynparza’s prostate opportunity
May 01, 2023
Apr 28, 2023
-
Science
Who is Monica Bertagnolli, Biden’s pick to lead NIH?
-
Politico
The real reason Europe’s medicines industry is dying
-
The Wall Street Journal
Congress Considers Paying Developers of New Antibiotics
-
MedTech Dive
Illumina gets cybersecurity warning from FDA over sequencing software
Apr 27, 2023
Apr 26, 2023
-
The Wall Street Journal
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut
-
Reuters
EU publishes proposed drug laws overhaul, setting up tussle with industry
-
Evaluate Vantage
GSK says more deals to come as oncology takes another blow
-
C&EN
Drug services providers gird for an oligonucleotide surge
Apr 25, 2023
-
The Wall Street Journal
Weight-Loss Drugmakers Lobby for Medicare Coverage
-
Axios
Lyme disease vaccine could be coming soon
-
MarketWatch
Assertio to Acquire Outstanding Shares of Spectrum Pharmaceuticals
Previous
